Epiroc AB (publ) (EPIAF)
OTC: EPIAF
· Real-Time Price · USD
20.52
0.08 (0.40%)
At close: Aug 21, 2025, 10:29 AM
Epiroc AB (publ) Income Statement
Financials in SEK. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.13B | 15.54B | 17.25B | 15.7B | 16.51B | 14.14B | 15.57B | 15B | 15.91B | 13.87B | 13.94B | 12.8B | 11.87B | 11.09B | 11.17B | 9.97B | 9.73B | 8.77B |
Cost of Revenue | 9.46B | 9.4B | 11.26B | 9.87B | 10.56B | 8.96B | 9.82B | 9.22B | 9.89B | 8.27B | 8.14B | 7.89B | 7.81B | 6.83B | 6.86B | 6B | 5.9B | 5.43B |
Gross Profit | 5.67B | 6.14B | 5.99B | 5.83B | 5.95B | 5.18B | 5.75B | 5.78B | 6.02B | 5.6B | 5.79B | 4.91B | 4.05B | 4.26B | 4.31B | 3.97B | 3.83B | 3.34B |
Operating Income | 2.83B | 3.09B | 3.43B | 3.28B | 3.35B | 2.64B | 3.17B | 3.26B | 3.41B | 3.16B | 3.23B | 2.9B | 2.38B | 2.63B | 2.59B | 2.35B | 2.18B | 1.87B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 2.7B | 2.88B | 3.13B | 3.01B | 2.66B | 2.64B | 2.91B | 2.93B | 3.43B | 2.96B | 3.05B | 2.88B | 2.29B | 2.56B | 2.57B | 2.42B | 2.14B | 1.83B |
Net Income | 2.1B | 2.2B | 2.36B | 2.32B | 2.04B | 2.01B | 2.26B | 2.23B | 2.65B | 2.29B | 2.39B | 2.24B | 1.77B | 2B | 2.05B | 1.93B | 1.69B | 1.39B |
Selling & General & Admin | 2.1B | 2.23B | 2.19B | 2.14B | 2.37B | 2.08B | 2.11B | 1.98B | 2.08B | 1.9B | 2.04B | 1.69B | 1.58B | 1.36B | 1.56B | 1.27B | 1.3B | 1.35B |
Research & Development | 505M | 500M | 513M | 771M | 537M | 461M | 464M | 517M | 497M | 452M | 396M | 360M | 363M | 319M | 360M | 300M | 283M | 229M |
Other Expenses | 233M | 327M | -142M | -367M | 537M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2.84B | 3.05B | 2.56B | 2.55B | 2.6B | 2.54B | 2.58B | 2.52B | 2.61B | 2.44B | 2.79B | 2.01B | 1.67B | 1.63B | 1.96B | 1.61B | 1.65B | 1.47B |
Interest Expense | n/a | n/a | n/a | n/a | 265M | 116M | 435M | 331M | n/a | 197M | 189M | 24M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 1.01B | 1.02B | 1.09B | 1.07B | 1.13B | 953M | 1.02B | 1B | 1.01B | 926M | 852M | 782M | 767M | 641M | 633M | 582M | 570M | 528M |
Cost & Expenses | 12.3B | 12.45B | 13.82B | 12.42B | 13.16B | 11.5B | 12.39B | 11.74B | 12.5B | 10.71B | 10.94B | 9.9B | 9.49B | 8.46B | 8.82B | 7.61B | 7.55B | 6.91B |
Income Tax Expense | 597M | 685M | 747M | 690M | 612M | 634M | 646M | 685M | 775M | 671M | 651M | 633M | 519M | 564M | 510M | 496M | 445M | 444M |
Shares Outstanding (Basic) | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.2B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B |
Shares Outstanding (Diluted) | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B | 1.21B |
EPS (Basic) | 1.74 | 1.82 | 1.96 | 1.92 | 1.69 | 1.66 | 1.87 | 1.85 | 2.19 | 1.90 | 1.98 | 1.86 | 1.47 | 1.66 | 1.70 | 1.60 | 1.40 | 1.15 |
EPS (Diluted) | 1.74 | 1.82 | 1.96 | 1.92 | 1.69 | 1.66 | 1.87 | 1.85 | 2.19 | 1.90 | 1.98 | 1.85 | 1.47 | 1.65 | 1.70 | 1.59 | 1.40 | 1.15 |
EBITDA | 3.6B | 3.87B | 4.24B | 4.45B | 4.14B | 3.32B | 4.04B | 3.96B | 4.06B | 3.8B | 3.65B | 3.43B | 2.87B | 3.1B | 3.02B | 2.81B | 2.59B | 2.25B |
EBIT | 2.83B | 3.09B | 3.43B | 3.28B | 2.92B | 2.76B | 3.36B | 3.26B | 3.41B | 3.16B | 3.09B | 2.9B | 2.38B | 2.63B | 2.7B | 2.35B | 2.18B | 1.87B |
Depreciation & Amortization | 768M | 779M | 815M | 1.17B | 788M | 673M | 683M | 701M | 644M | 635M | 651M | 526M | 487M | 466M | 491M | 462M | 411M | 382M |